RMAH — Farmaceutica Remedia SA Share Price
Last trade - 00:00- RON66.06m
- RON33.69m
- RON593.36m
- 67
- 96
- 70
- 93
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.93 | ||
| Price to Tang. Book | 0.95 | ||
| Price to Free Cashflow | 3.02 | ||
| Price to Sales | 0.11 | ||
| EV to EBITDA | 2.46 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.86% | ||
| Return on Equity | 10.34% | ||
| Operating Margin | 1.37% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | RONm | 446.41 | 441.48 | 477.1 | 535.85 | 593.36 | n/a | n/a | 5.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +199.71 | -18.19 | +29.71 | -3.52 | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Farmaceutica Remedia SA is a Romania-based company principally engaged in the operation of pharmacies. The Company is active in the marketing, import and distribution of drugs. Additionally, it sells packing materials for pharmaceutical industry. The company operates approximately a network of 100 pharmacies and drugstores placed in Alba, Arad, Bucharest, Calarasi, Cluj, Dambovita, Dolj, Giurgiu, Hunedoara, Ilfov, Sibiu, Timis and Tulcea. Farmaceutica Remedia also operates eight logistic centers in Bucuresti, Deva, Brasov, Craiova, Iasi, Pitesti, Sibiu, Tg. Mures and Timisoara. The Company’s major shareholders are Tarus Valentin-Norbert, which owns 66.06% of shares, and AHG Vermogensverwaltungs GmbH Cottbus with 16.5%.
Directors
- Valentin Tarus NEC (67)
- Robert Peloiu FID
- Florin Lupas CAD
- Mihai Marin DSL
- Mihaela Cretu DHR
- Raluca Oncu OTH
- Mihaela Tache OTH
- Daniela Vasile OTH
- Lucian Codreanu DRC (51)
- Petru Craciun DRC (53)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 25th, 1991
- Public Since
- December 5th, 1996
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- Bucharest Stock Exchange
- Shares in Issue
- 95,180,720
- Address
- Bd. Nicolae Balcescu nr. 2, DEVA, 330040
- Web
- https://corporate.remedia.ro/
- Phone
- +40 254223260
- Auditors
- Premier Class Audit
Upcoming Events for RMAH
Similar to RMAH
Alcom SA
Bucharest Stock Exchange
Alimentara SA
Bucharest Stock Exchange
Bucur SA
Bucharest Stock Exchange
Comaliment Resita Sa
Bucharest Stock Exchange
Comturist SA
Bucharest Stock Exchange
FAQ
As of Today at 19:08 UTC, shares in Farmaceutica Remedia SA are trading at RON0.69. This share price information is delayed by 15 minutes.
Shares in Farmaceutica Remedia SA last closed at RON0.69 and the price had moved by +9.29% over the past 365 days. In terms of relative price strength the Farmaceutica Remedia SA share price has outperformed the FTSE Global All Cap Index by +0.81% over the past year.
There is no consensus recommendation for this security.
Farmaceutica Remedia SA does not currently pay a dividend.
Farmaceutica Remedia SA does not currently pay a dividend.
Farmaceutica Remedia SA does not currently pay a dividend.
To buy shares in Farmaceutica Remedia SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of RON0.69, shares in Farmaceutica Remedia SA had a market capitalisation of RON66.06m.
Here are the trading details for Farmaceutica Remedia SA:
- Country of listing: Romania
- Exchange: BUH
- Ticker Symbol: RMAH
Based on an overall assessment of its quality, value and momentum Farmaceutica Remedia SA is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Farmaceutica Remedia SA is RON0.71. That is 2.31% above the last closing price of RON0.69.
Analysts covering Farmaceutica Remedia SA currently have a consensus Earnings Per Share (EPS) forecast of RON0.07 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Farmaceutica Remedia SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -6.07%.
As of the last closing price of RON0.69, shares in Farmaceutica Remedia SA were trading +1.89% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Farmaceutica Remedia SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at RON0.69.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Farmaceutica Remedia SA's management team is headed by:
- Valentin Tarus - NEC
- Robert Peloiu - FID
- Florin Lupas - CAD
- Mihai Marin - DSL
- Mihaela Cretu - DHR
- Raluca Oncu - OTH
- Mihaela Tache - OTH
- Daniela Vasile - OTH
- Lucian Codreanu - DRC
- Petru Craciun - DRC